BioSpace News Archive

Mustang Bio, Inc. announced financial results and recent corporate highlights for the first quarter ended March 31, 2023.

HilleVax, Inc. reported financial results for the quarter ended March 31, 2023, highlighted recent progress and outlined key upcoming milestones for HIL-214, the company’s investigational virus-like particle based vaccine for the prevention of moderate-to-severe norovirus-related acute gastroenteritis.

Clene Inc. and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, announced its first quarter 2023 financial results and provided recent operating highlights for the clinical programs in amyotrophic lateral sclerosis and multiple sclerosis.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

AgeX Therapeutics, Inc., a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023.

Innate Pharma SA announced the voting results of its shareholders at the Annual General Meeting, which took place on May 12, 2023, in Marseille.

BELLUS Health Inc. reported its financial and operating results for the quarter ended March 31, 2023.

Centene Corporation announced it will present at the Bernstein 39th Annual Strategic Decisions Conference, to be held Wednesday, May 31-Friday, June 2, 2023, in New York City.

Zomedica Corp. announced that Larry Heaton, Chief Executive Officer, will be participating in a Company Webcast and Panel Presentation at the Lytham Partners Spring 2023 Investor Conference on Thursday, May 18, 2023.

Ainos, Inc. announced its financial results for the first quarter ended March 31, 2023.